Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease.

Barbour SJ, Cattran DC, Kim SJ, Levin A, Wald R, Hladunewich MA, Reich HN.

Kidney Int. 2013 Nov;84(5):1017-24. doi: 10.1038/ki.2013.210. Epub 2013 Jun 5. Erratum in: Kidney Int. 2015 Jan;87(1):242.

PMID:
23739233
2.

Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.

Zhang J, Wang C, Tang Y, Peng H, Ye ZC, Li CC, Lou TQ.

Nephrology (Carlton). 2013 Feb;18(2):125-31. doi: 10.1111/nep.12010.

PMID:
23134230
3.

Clinical outcomes and predictors for ESRD and mortality in primary GN.

Chou YH, Lien YC, Hu FC, Lin WC, Kao CC, Lai CF, Chiang WC, Lin SL, Tsai TJ, Wu KD, Chen YM.

Clin J Am Soc Nephrol. 2012 Sep;7(9):1401-8. Epub 2012 Jul 12.

4.

Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.

Zhang L, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, De Zoysa J, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW.

Nephrology (Carlton). 2016 May;21(5):387-96. doi: 10.1111/nep.12629.

PMID:
26393772
5.

Progression of IgA nephropathy under current therapy regimen in a Chinese population.

Li X, Liu Y, Lv J, Shi S, Liu L, Chen Y, Zhang H.

Clin J Am Soc Nephrol. 2014 Mar;9(3):484-9. doi: 10.2215/CJN.01990213. Epub 2014 Jan 9.

6.

Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.

Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Tsuchimoto A, Noguchi H, Hirakata H, Tsuruya K, Kitazono T.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2082-90. doi: 10.2215/CJN.03480413. Epub 2013 Oct 31.

7.

Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.

Knoop T, Vågane AM, Vikse BE, Svarstad E, Magnúsdóttir BT, Leh S, Varberg Reisæter A, Bjørneklett R.

Am J Nephrol. 2015;41(3):210-9. doi: 10.1159/000381403. Epub 2015 Apr 9.

8.

The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care.

De Nicola L, Minutolo R, Chiodini P, Borrelli S, Zoccali C, Postorino M, Iodice C, Nappi F, Fuiano G, Gallo C, Conte G; Italian Society of Nephrology Study Group Target Blood pressure Levels (TABLE) in CKD..

Kidney Int. 2012 Aug;82(4):482-8.

9.

Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.

Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.

J Nephrol. 2012 Sep-Oct;25(5):810-8. doi: 10.5301/jn.5000069.

PMID:
22252844
10.

Validation of chronic kidney disease risk categorization system in Chinese patients with kidney disease: A cohort study.

Liu Q, Lv J, Li H, Jiao L, Yang H, Song Y, Xu G.

Nephrology (Carlton). 2015 Dec;20(12):936-44. doi: 10.1111/nep.12528.

PMID:
26032648
11.

Patient characteristics and outcomes by GN subtype in ESRD.

O'Shaughnessy MM, Montez-Rath ME, Lafayette RA, Winkelmayer WC.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1170-8. doi: 10.2215/CJN.11261114. Epub 2015 Jun 19.

12.

Primary glomerulonephritis: an update on renal survival and determinants of progression.

Moranne O, Watier L, Rossert J, Stengel B; GN-Progress Study Group..

QJM. 2008 Mar;101(3):215-24. doi: 10.1093/qjmed/hcm142. Epub 2008 Feb 2.

PMID:
18245806
13.

Optimal proteinuria target for renoprotection in patients with IgA nephropathy.

Nam KH, Kie JH, Lee MJ, Chang TI, Kang EW, Kim DW, Lim BJ, Park JT, Kwon YE, Kim YL, Park KS, An SY, Oh HJ, Yoo TH, Kang SW, Choi KH, Jeong HJ, Han DS, Han SH.

PLoS One. 2014 Jul 8;9(7):e101935. doi: 10.1371/journal.pone.0101935. eCollection 2014.

14.

Kidney function before pancreas transplant alone predicts subsequent risk of end-stage renal disease.

Kim SJ, Smail N, Paraskevas S, Schiff J, Cantarovich M.

Transplantation. 2014 Mar 27;97(6):675-80. doi: 10.1097/01.TP.0000437556.87109.45.

PMID:
24637866
15.

Independent or synergistic relationship of proteinuria and glomerular filtration rate on patient and renal survival in patients with glomerulonephritis?

Haider DG, Masghati S, Goliasch G, Fuhrmann V, Soleiman A, Wolzt M, Baierl A, Druml W, Hörl WH.

J Nephrol. 2014 Dec;27(6):643-51. doi: 10.1007/s40620-014-0074-z. Epub 2014 Mar 8.

PMID:
24609889
16.

Association of C4d deposition with clinical outcomes in IgA nephropathy.

Espinosa M, Ortega R, Sánchez M, Segarra A, Salcedo MT, González F, Camacho R, Valdivia MA, Cabrera R, López K, Pinedo F, Gutierrez E, Valera A, Leon M, Cobo MA, Rodriguez R, Ballarín J, Arce Y, García B, Muñoz MD, Praga M; Spanish Group for Study of Glomerular Diseases (GLOSEN)..

Clin J Am Soc Nephrol. 2014 May;9(5):897-904. doi: 10.2215/CJN.09710913. Epub 2014 Feb 27.

17.

Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.

Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.

Nephrology (Carlton). 2008 Jun;13(3):242-6. doi: 10.1111/j.1440-1797.2007.00898.x. Epub 2008 Jan 23.

PMID:
18221258
18.

Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.

Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z.

Nephrol Dial Transplant. 2012 Apr;27(4):1479-85. doi: 10.1093/ndt/gfr527. Epub 2011 Sep 29.

PMID:
21965586
19.

The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.

Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Nagata M, Tsuchimoto A, Hirakata H, Kitazono T, Tsuruya K.

Clin Exp Nephrol. 2016 Oct;20(5):689-698. Epub 2015 Nov 12.

PMID:
26564155
20.

Mortality of IgA nephropathy patients: a single center experience over 30 years.

Lee H, Kim DK, Oh KH, Joo KW, Kim YS, Chae DW, Kim S, Chin HJ.

PLoS One. 2012;7(12):e51225. doi: 10.1371/journal.pone.0051225. Epub 2012 Dec 4.

Supplemental Content

Support Center